DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening

References

• Tabor CW, Tabor H. 1, 4-diaminobutane (putrescine), spermidine, and spermine. Annu Rev Biochem. 1976;45(1):285–306.
   PubMedGoogle Scholar
• Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988;48(4):759–774.
   PubMed Web of Science ®Google Scholar
• Gerner EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004;4(10):781–792.
   PubMed Web of Science ®Google Scholar
• Casero RA, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov. 2007;6(5):373–390.
   PubMed Web of Science ®Google Scholar
• LoGiudice N, Le L, Abuan I, Leizorek Y, Roberts SC. Alpha-difluoromethylornithine, an irreversible inhibitor of polyamine biosynthesis, as a therapeutic strategy against hyperproliferative and infectious diseases. Med Sci. 2018;6(1):12.
   Google Scholar
• Ju YH, Bhalla M, Hyeon SJ, Oh JE, Yoo S, Chae U, Kwon J, Koh W, Lim J, Park YM, et al. Astrocytic urea cycle detoxifies aβ-derived ammonia while impairing memory in Alzheimer’s disease. Cell Metab . 2022;34(8):1104–1120.e8.
   PubMed Web of Science ®Google Scholar
• Casero RA, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18(11):681–695.
   PubMed Web of Science ®Google Scholar
• Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol. 1995;35(1):55–91.
   PubMedGoogle Scholar
• Wallace H, Fraser A. Inhibitors of polyamine metabolism. Amino Acids. 2004;26(4):353–365.
   PubMed Web of Science ®Google Scholar
• Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Baudin E, Buard V, Kazadi-Kyanza S, et al. Nifurtimox-eflornithine combination therapy for second-stage african trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase iii, non-inferiority trial. Lancet. 2009;374(9683):56–64.
   PubMed Web of Science ®Google Scholar
• Alirol E, Schrumpf D, Amici Heradi J, Riedel A, de Patoul C, Quere M, Chappuis F. Nifurtimox-eflornithine combination therapy for second-stage gambiense human african trypanosomiasis: Médecins sans frontières experience in the democratic republic of the congo. Clin Infect Dis. 2013;56(2):195–203.
   PubMed Web of Science ®Google Scholar
• Heby O, Persson L, Rentala M. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasis. Amino Acids. 2007;33(2):359–366.
   PubMed Web of Science ®Google Scholar
• Moinard C, Cynober L, de Bandt J-P. Polyamines: metabolism and implications in human diseases. Clin Nutr. 2005;24(2):184–197.
   PubMed Web of Science ®Google Scholar
• Blume‐Peytavi U, Hahn S. Medical treatment of hirsutism. Dermatol Ther. 2008;21(5):329–339.
   PubMed Web of Science ®Google Scholar
• Jackson J, Caro JJ, Caro G, Garfield F, Huber F, Zhou W, Lin CS, Shander D, Schrode K, Group EHS. The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism. Int J Dermatol. 2007;46(9):976–981.
   PubMed Web of Science ®Google Scholar
• Schultz CR, Swanson MA, Dowling TC, Bachmann AS. Probenecid increases renal retention and antitumor activity of dfmo in neuroblastoma. Cancer Chemother Pharmacol. 2021;88(4):607–617.
   PubMed Web of Science ®Google Scholar
• Sholler GLS, Ferguson W, Bergendahl G, Bond JP, Neville K, Eslin D, Brown V, Roberts W, Wada RK, Oesterheld J, et al. Maintenance dfmo increases survival in high risk neuroblastoma. Sci Rep. 2018;8(1):1–9.
   PubMedGoogle Scholar
• Schultz CR, Bupp CP, Rajasekaran S, Bachmann AS. Biochemical features of primary cells from a pediatric patient with a gain-of-function odc1 genetic mutation. Biochem J. 2019;476(14):2047–2057.
   PubMedGoogle Scholar
• Bupp CP, Schultz CR, Uhl KL, Rajasekaran S, Bachmann AS. Novel de novo pathogenic variant in the odc1 gene in a girl with developmental delay, alopecia, and dysmorphic features. Am J Med Genet A. 2018;176(12):2548–2553.
   PubMed Web of Science ®Google Scholar
• Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem. 2006;281(21):14529–14532.
   PubMed Web of Science ®Google Scholar
• Mitchell JL, Chen HJ. Conformational changes in ornithine decarboxylase enable recognition by antizyme. Biochimica et Biophysica Acta (BBA)-Protein Struc Mol Enzymol. 1990;1037(1):115–121.
   PubMedGoogle Scholar
• Nowotarski SL, Woster PM, Casero RA. Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med. 2013;15:3.
   PubMed Web of Science ®Google Scholar
• Chai X, Zhan J, Pan J, He M, Li B, Wang J, Ma H, Wang Y, Liu S. The rational discovery of multipurpose inhibitors of the ornithine decarboxylase. Faseb J. 2020;34(9):10907–12921.
   PubMed Web of Science ®Google Scholar
• Schultz CR, Gruhlke MC, Slusarenko AJ, Bachmann AS. Allicin, a potent new ornithine decarboxylase inhibitor in neuroblastoma cells. J Nat Prod. 2020;83(8):2518–2527.
   PubMed Web of Science ®Google Scholar
• Rajasekaran S, Bupp CP, Leimanis-Laurens M, Shukla A, Russell C, Junewick J, Gleason E, VanSickle EA, Edgerly Y, Wittmann BM, et al. Repurposing eflornithine to treat a patient with a rare odc1 gain-of-function variant disease. Elife. 2021;10:e67097.
   PubMed Web of Science ®Google Scholar
• Dsouza RN, Hennig A, Nau WM. Supramolecular tandem enzyme assays. Chemistry. 2012;18(12):3444–3459.
   PubMed Web of Science ®Google Scholar
• Nilam M, Gribbon P, Reinshagen J, Cordts K, Schwedhelm E, Nau WM, Hennig A. A label-free continuous fluorescence-based assay for monitoring ornithine decarboxylase activity with a synthetic putrescine receptor. SLAS Discov. 2017;22(7):906–914.
   PubMed Web of Science ®Google Scholar
• Hennig A, Bakirci H, Nau WM. Label-free continuous enzyme assays with macrocycle-fluorescent dye complexes. Nat Methods. 2007;4(8):629–632.
   PubMed Web of Science ®Google Scholar
• Nau WM, Ghale G, Hennig A, Bakirci H, Bailey DM. Substrate-selective supramolecular tandem assays: monitoring enzyme inhibition of arginase and diamine oxidase by fluorescent dye displacement from calixarene and cucurbituril macrocycles. J Am Chem Soc. 2009;131(32):11558–11570.
   PubMed Web of Science ®Google Scholar
• Biedermann F, Uzunova VD, Scherman OA, Nau WM, De Simone A. Release of high-energy water as an essential driving force for the high-affinity binding of cucurbit [n] urils. J Am Chem Soc. 2012;134(37):15318–15323.
   PubMed Web of Science ®Google Scholar
• Zhou XE, Suino-Powell K, Schultz CR, Aleiwi B, Brunzelle JS, Lamp J, Vega IE, Ellsworth E, Bachmann AS, Melcher K. Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane. Biochem J. 2021;478(23):4137–4149.
   PubMed Web of Science ®Google Scholar
• Zhou XE, Schultz CR, Suino Powell K, Henrickson A, Lamp J, Brunzelle JS, Demeler B, Vega IE, Bachmann AS, Melcher K. Structure and enzymatic activity of an intellectual disability-associated ornithine decarboxylase variant, g84r. ACS omega; 2022.
   Google Scholar
• Bhatwa A, Wang W, Hassan YI, Abraham N, Li X-Z, Zhou T. Challenges associated with the formation of recombinant protein inclusion bodies in escherichia coli and strategies to address them for industrial applications. Front Bioeng Biotechnol. 2021;9:630551.
   PubMed Web of Science ®Google Scholar
• Sørensen HP. Towards universal systems for recombinant gene expression. Microb Cell Fact. 2010;9(1):27–4.
   PubMedGoogle Scholar
• Walsh G. Post-translational modifications of protein biopharmaceuticals. Drug Discov Today. 2010;15(17–18):773–780.
   PubMed Web of Science ®Google Scholar
• Park MG, Han A-r, Kim SY, Kim TY, Kim HM, Lee CJ. High-yield synthesis and purification of recombinant human gaba transaminase for high-throughput screening assays. J Enzyme Inhib Med Chem. 2021;36(1):2016–2024.
   PubMed Web of Science ®Google Scholar
• Wolpaw DR, Schwartz AL. Ornithine decarboxylase activity in human fetal liver. Pediatr Res. 1976;10(4):224–226.
   PubMed Web of Science ®Google Scholar
• Lin C-Y, Huang Z, Wen W, Wu A, Wang C, Niu L. Enhancing protein expression in hek-293 cells by lowering culture temperature. PLoS One. 2015;10(4):e0123562.
   PubMed Web of Science ®Google Scholar
• Elegheert J, Behiels E, Bishop B, Scott S, Woolley RE, Griffiths SC, Byrne EFX, Chang VT, Stuart DI, Jones EY, et al. Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins. Nat Protoc. 2018;13(12):2991–3017.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li G, Liang S. Several affinity tags commonly used in chromatographic purification. J Anal Methods Chem. 2013;2013:581093.
   PubMed Web of Science ®Google Scholar
• Maertens B, Spriestersbach A, Kubicek J, Schäfer F. Strep-tagged protein purification. In: Strep-tagged protein purification. Methods in enzymology. Amsterdam: Elsevier; 2015.
   Google Scholar
• Wu D, Kaan HYK, Zheng X, Tang X, He Y, Vanessa Tan Q, Zhang N, Song H. Structural basis of ornithine decarboxylase inactivation and accelerated degradation by polyamine sensor antizyme1. Sci Rep. 2015;5(1):14738–14738.
   PubMedGoogle Scholar
• Zhang J-H, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4(2):67–73.
   PubMed Web of Science ®Google Scholar
• Nilam M, Hennig A. Enzyme assays with supramolecular chemosensors–the label-free approach. RSC Adv. 2022;12(17):10725–10748.
   PubMed Web of Science ®Google Scholar
• Grishin NV, Osterman AL, Brooks HB, Phillips MA, Goldsmith EJ. X-ray structure of ornithine decarboxylase from trypanosoma brucei: the native structure and the structure in complex with α-difluoromethylornithine. Biochemistry. 1999;38(46):15174–15184.
   PubMed Web of Science ®Google Scholar